Planned Parenthood lacks support for detransitioners despite offering transition hormones, probe reveals

A recent undercover investigation conducted by detransitioner Chloe Cole in partnership with pro-life advocacy organization Live Action has exposed significant gaps in healthcare services for individuals seeking to reverse gender transitions. The probe involved phone calls to multiple Planned Parenthood facilities across Idaho, Alaska, New York, Washington D.C., and other states, during which Cole posed as a patient requesting information about detransitioning after previously undergoing gender-affirming medical treatment. The findings revealed that while the organization readily provides hormone therapy and transition-related services, it offers virtually no support, resources, or clinical pathways for those who regret their transition and wish to reverse course.

During the recorded conversations, Planned Parenthood employees consistently acknowledged the availability of gender-affirming care services but failed to identify any detransition-specific programs when Cole asked about options for reversing prior transition-related medical interventions. “We only have gender-affirming care services, like for hormones, but not to detransition,” one employee stated during a call. When Cole inquired about help addressing fertility concerns or other effects associated with previous transition treatments, the staff member responded: “As in right now, it’s a no, I don’t think we do that type of healthcare.”

Employee responses highlight one-directional care model

Throughout multiple calls reviewed during the investigation, Cole raised specific concerns about fertility restoration, the long-term effects of cross-sex hormones, breast reconstruction options, and other medical questions directly related to detransitioning. According to the investigation findings, employees typically responded by referring her to outside providers, stating they were unfamiliar with detransition-related care, or confirming that such services were not offered through Planned Parenthood facilities. In one exchange, Cole told a staff member, “I had surgery, I’ve been on the drugs, and I need help recovering the things I’ve lost,” while asking what resources might be available.

The employee replied that Planned Parenthood could schedule an appointment with a provider but added, “I don’t think we do that type of healthcare.” Another staff member indicated during a separate call that Planned Parenthood facilities typically see patients who are “getting started on gender-affirming care,” further suggesting the organization’s focus remains on initiating transitions rather than supporting those who wish to discontinue or reverse them. The investigation revealed a pattern across multiple states and locations of what advocates describe as a one-way system that pushes individuals toward transition without providing adequate support for those who change their minds.

Cole’s personal experience drives investigation effort

For Chloe Cole, the investigation holds deeply personal significance. She began the process of attempting to change her gender from female to male at age 12, underwent a double mastectomy at 15, and started detransitioning at 16 after realizing the medical interventions were harming her body. “I know firsthand the pain of being pushed down the path of transition,” Cole stated. “In this investigation with Live Action, I wanted to see what Planned Parenthood would do when someone came back asking for help to detransition.”

Cole described the findings as horrifying. “What I found was horrifying: Planned Parenthood was ready to help people start transitioning, but had no real answers, no meaningful support, and no services to help them reverse course,” she said. Her experience reflects growing concerns among detransitioners who report feeling abandoned by the same medical systems that encouraged their original transitions. The investigation builds on Cole’s ongoing advocacy work to raise awareness about the long-term consequences of gender-affirming medical interventions performed on minors and the lack of comprehensive support for individuals who regret those decisions.

Investigation follows previous findings on hormone access for minors

The new probe follows a separate undercover investigation reported in May that found some Planned Parenthood locations indicated minors as young as 16 could obtain cross-sex hormones through the organization’s informed-consent model with minimal requirements for therapy or mental health evaluations. That earlier investigation by Live Action released recordings from calls to Planned Parenthood facilities in multiple states in which employees allegedly stated cross-sex hormones could be prescribed at an initial appointment. The latest investigation shifts focus to examine what support exists for individuals seeking to discontinue treatment or detransition after beginning gender-affirming medical care.

• Calls were made to Planned Parenthood locations in Idaho, Alaska, New York, and Washington D.C.
• Employees consistently acknowledged gender-affirming services but no detransition programs.
• Staff referred Cole to outside providers or stated unfamiliarity with reversal care.
• Previous May investigation found minimal oversight for hormone prescriptions to minors.
• Planned Parenthood website lists hormone therapy, puberty blockers, and surgery referrals.

Live Action founder and president Lila Rose described the investigation results as evidence of what she called a “one-way body destruction pipeline.” Rose stated: “Planned Parenthood is willing to prescribe cross-sex hormones and push vulnerable people further into dangerous so-called ‘gender-affirming care,’ but when someone comes back seeking help to detransition, Planned Parenthood has no answers, no support and no services to help reverse the damage.” The organization is using the investigation as part of a broader campaign urging lawmakers to maintain restrictions on federal funding for Planned Parenthood.

Organization’s website details transition services but omits reversal support

Planned Parenthood’s official website states that many of its health centers provide gender-affirming care and lists services including hormone therapy, puberty blockers, surgery referrals, and “transition support (social, legal).” However, the website does not specifically reference detransition-related services on its gender-affirming care page. The organization notes that not all Planned Parenthood health centers offer the same services, with availability varying by location. This inconsistency across facilities adds another layer of complexity for individuals seeking either transition or detransition support.

Live Action is leveraging the investigation findings to pressure Congress and the current administration to continue restricting federal funding for Planned Parenthood after current limitations expire. The advocacy group argues that the organization’s expansion of transgender-related healthcare services in recent years has prioritized ideologically driven care over comprehensive medical support that would include helping individuals who regret transition decisions. According to the organization’s most recent publicly available data, Planned Parenthood has significantly increased its gender-affirming care offerings across its nationwide network of health centers, though specific detransition protocols remain absent from publicly listed services.

Growing debate over transition care and reversal options intensifies

The investigation arrives amid intensifying national debate over gender-affirming care for minors and the adequacy of informed consent processes. Detransitioners like Cole have become increasingly vocal about their experiences, with some pursuing legal action against medical providers for what they describe as inadequate evaluation and rushed treatment decisions. Cole has previously advocated for legislation aimed at blocking minors from undergoing life-altering transgender surgeries and has spoken publicly about what she characterizes as a lack of proper safeguards in the current system.

The findings raise questions about medical ethics, informed consent, and the responsibilities of healthcare providers to offer comprehensive care that includes support for patients who change their minds about transition. As more individuals come forward with detransition stories, pressure is mounting on organizations that provide gender-affirming care to develop robust protocols for supporting patients throughout their entire healthcare journey, including reversal options when requested. The investigation suggests a significant gap between the resources available to begin transition and those available to reverse it, a disparity that advocates argue leaves vulnerable individuals without adequate medical support during critical periods of their lives.